Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis

Publisher: John Wiley & Sons Inc

E-ISSN: 1860-7187|13|4|321-337

ISSN: 1860-7179

Source: CHEMMEDCHEM, Vol.13, Iss.4, 2018-02, pp. : 321-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract